Form4insider filings, from the source

Insider holders · CIK 0002058707

Attovia Therapeutics, Inc. · ATTO

Every insider with a reported Table I holding at this company, ranked by their last-reported share count. A balance is only as fresh as its filing — the report date sits next to every row on purpose. ← Back to activity

InsiderDirect sharesIndirect sharesTotal reportedLast report (ET)From
FHMLS XI, L.L.C.10% Owner6,154,213—6,154,213Aug 6, 2026 · 5:35 pm EDTForm 4
Frazier Life Sciences XI, L.P.10% Owner6,154,213—6,154,213Aug 6, 2026 · 5:35 pm EDTForm 4
FHMLS XI, L.P.10% Owner6,154,213—6,154,213Aug 6, 2026 · 5:35 pm EDTForm 4
venBio Global Strategic Fund IV, L.P.10% Owner4,181,367—4,181,367Aug 10, 2026 · 4:12 pm EDTForm 4
Alamar HoldCo, LLC10% Owner3,229,278—3,229,278Aug 5, 2026 · 7:19 pm EDTForm 3
WSLS EMP ONSHORE INVESTMENTS, L.P.relationship not stated—3,020,6323,020,632Aug 28, 2026 · 5:38 pm EDTForm 4/A
WSLS OFFSHORE INVESTMENTS, SLPrelationship not stated—3,020,6323,020,632Aug 28, 2026 · 5:38 pm EDTForm 4/A
WSLS EMP OFFSHORE INVESTMENTS, L.P.relationship not stated—3,020,6323,020,632Aug 28, 2026 · 5:38 pm EDTForm 4/A
West Street Life Sciences I, L.P.relationship not stated—3,020,6323,020,632Aug 28, 2026 · 5:38 pm EDTForm 4/A
Colin WalshDirector—3,020,6323,020,632Aug 28, 2026 · 5:38 pm EDTForm 4/A
Broad Street Principal Investments, L.L.C.relationship not stated—3,020,6323,020,632Aug 28, 2026 · 5:38 pm EDTForm 4/A
GOLDMAN SACHS ASSET MANAGEMENT, L.P.relationship not stated—3,020,6323,020,632Aug 28, 2026 · 5:38 pm EDTForm 4/A
GOLDMAN SACHS GROUP INCrelationship not stated—3,020,6323,020,632Aug 28, 2026 · 5:38 pm EDTForm 4/A
GOLDMAN SACHS & CO. LLCrelationship not stated—3,020,6323,020,632Aug 28, 2026 · 5:38 pm EDTForm 4/A
Redmile Biopharma Investments III, L.P.10% Owner982,8541,182,8542,165,708Aug 7, 2026 · 9:47 pm EDTForm 4
Jeremy Green10% Owner982,8541,182,8542,165,708Aug 7, 2026 · 9:47 pm EDTForm 4
Redmile Group, LLC10% Owner982,8541,182,8542,165,708Aug 7, 2026 · 9:47 pm EDTForm 4
Deep Track Biotechnology Master Fund, Ltd.10% Owner1,957,138—1,957,138Aug 10, 2026 · 4:30 pm EDTForm 4
Deep Track Capital, LP10% Owner1,957,138—1,957,138Aug 10, 2026 · 4:30 pm EDTForm 4
David Kroin10% Owner1,957,138—1,957,138Aug 10, 2026 · 4:30 pm EDTForm 4
Sanofi10% Owner—1,082,8551,082,855Aug 7, 2026 · 3:45 pm EDTForm 4
Attovia Therapeutics, Inc.President and CEO87,843245,425333,268Aug 4, 2026 · 7:31 pm EDTForm 3
Petter VeibyChief Scientific Officer104,951—104,951Aug 4, 2026 · 7:36 pm EDTForm 3
Zaneta OdrowazChief Business Officer103,269—103,269Aug 4, 2026 · 7:33 pm EDTForm 3
Angie YouDirector52,852—52,852Aug 4, 2026 · 7:38 pm EDTForm 3
Hubert ChenChief Medical Officer2,960—2,960Aug 4, 2026 · 7:30 pm EDTForm 3

Balances come from each insider’s most recent filing that reports a Table I holding; an insider who left the company years ago still appears with their last-known figure and its date. Indirect totals collapse multiple vehicles (trusts, LLCs) into one number — open the filing for the breakdown. Shares as filed, not split-adjusted.